Literature DB >> 3200837

A free-energy perturbation study of the binding of methotrexate to mutants of dihydrofolate reductase.

U C Singh1, S J Benkovic.   

Abstract

The importance of hydrophobic residues to the binding of methotrexate in the active site of dihydrofolate reductase (EC 1.5.1.3) was examined by a free-energy perturbation method. The replacement of a strictly conserved residue, Phe-31, by tyrosine or valine costs 1.8 and 5.1 kcal/mol, respectively, to the binding of the drug (1 cal = 4.184 J). In the case of the Phe31----Tyr mutation, the loss of the binding energy is due to the desolvation of the phenolic group; in the case of Phe31----Val mutation, it is mainly due to the loss of the interaction with the drug. The replacement of Leu-54 by glycine decreases the binding energy by 4.0 kcal/mol. A calculation on the mutation of Phe-31 to serine shows that the alteration could reduce the binding energy of methotrexate by 9.7 kcal/mol. The calculations clearly show that the hydrophobic interactions are as important as the hydrophilic ones in the binding of methotrexate.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3200837      PMCID: PMC282785          DOI: 10.1073/pnas.85.24.9519

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  8 in total

1.  Identification of the 1H resonances of valine and leucine residues in dihydrofolate reductase by using a combination of selective deuteration and two-dimensional correlation spectroscopy.

Authors:  M S Searle; S J Hammond; B Birdsall; G C Roberts; J Feeney; R W King; D V Griffiths
Journal:  FEBS Lett       Date:  1986-01-01       Impact factor: 4.124

2.  Probing the salt bridge in the dihydrofolate reductase-methotrexate complex by using the coordinate-coupled free-energy perturbation method.

Authors:  U C Singh
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

Review 3.  Recent progress in the medicinal chemistry of 2,4-diaminopyrimidines.

Authors:  B Roth; C C Cheng
Journal:  Prog Med Chem       Date:  1982

4.  Dihydrofolate reductase. 1H resonance assignments and coenzyme-induced conformational changes.

Authors:  S J Hammond; B Birdsall; M S Searle; G C Roberts; J Feeney
Journal:  J Mol Biol       Date:  1986-03-05       Impact factor: 5.469

5.  Calculation of the relative change in binding free energy of a protein-inhibitor complex.

Authors:  P A Bash; U C Singh; F K Brown; R Langridge; P A Kollman
Journal:  Science       Date:  1987-01-30       Impact factor: 47.728

6.  Functional role of aspartic acid-27 in dihydrofolate reductase revealed by mutagenesis.

Authors:  E E Howell; J E Villafranca; M S Warren; S J Oatley; J Kraut
Journal:  Science       Date:  1986-03-07       Impact factor: 47.728

7.  Evaluation of the importance of hydrophobic interactions in drug binding to dihydrofolate reductase.

Authors:  K Taira; S J Benkovic
Journal:  J Med Chem       Date:  1988-01       Impact factor: 7.446

8.  Crystal structures of Escherichia coli and Lactobacillus casei dihydrofolate reductase refined at 1.7 A resolution. I. General features and binding of methotrexate.

Authors:  J T Bolin; D J Filman; D A Matthews; R C Hamlin; J Kraut
Journal:  J Biol Chem       Date:  1982-11-25       Impact factor: 5.157

  8 in total
  9 in total

1.  Relative solvation free energies calculated using an ab initio QM/MM-based free energy perturbation method: dependence of results on simulation length.

Authors:  M Rami Reddy; Mark D Erion
Journal:  J Comput Aided Mol Des       Date:  2009-09-17       Impact factor: 3.686

2.  Computation of affinity and selectivity: binding of 2,4-diaminopteridine and 2,4-diaminoquinazoline inhibitors to dihydrofolate reductases.

Authors:  J Marelius; M Graffner-Nordberg; T Hansson; A Hallberg; J Aqvist
Journal:  J Comput Aided Mol Des       Date:  1998-03       Impact factor: 3.686

3.  Refolding of Escherichia coli dihydrofolate reductase: sequential formation of substrate binding sites.

Authors:  C Frieden
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

4.  Decomposing the energetic impact of drug resistant mutations in HIV-1 protease on binding DRV.

Authors:  Yufeng Cai; Celia A Schiffer
Journal:  J Chem Theory Comput       Date:  2010-04-13       Impact factor: 6.006

5.  On achieving better than 1-A accuracy in a simulation of a large protein: Streptomyces griseus protease A.

Authors:  D H Kitson; F Avbelj; J Moult; D T Nguyen; J E Mertz; D Hadzi; A T Hagler
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

6.  Effects of fluorine substitution on the structure and dynamics of complexes of dihydrofolate reductase (Escherichia coli).

Authors:  E Y Lau; J T Gerig
Journal:  Biophys J       Date:  1997-09       Impact factor: 4.033

7.  Computer-aided drug design: a free energy perturbation study on the binding of methyl-substituted pterins and N5-deazapterins to dihydrofolate reductase.

Authors:  P L Cummins; J E Gready
Journal:  J Comput Aided Mol Des       Date:  1993-10       Impact factor: 3.686

8.  Relative differences in the binding free energies of human immunodeficiency virus 1 protease inhibitors: a thermodynamic cycle-perturbation approach.

Authors:  M R Reddy; V N Viswanadhan; J N Weinstein
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

9.  Molecular Basis for Drug Resistance in HIV-1 Protease.

Authors:  Akbar Ali; Rajintha M Bandaranayake; Yufeng Cai; Nancy M King; Madhavi Kolli; Seema Mittal; Jennifer F Murzycki; Madhavi N L Nalam; Ellen A Nalivaika; Ayşegül Özen; Moses M Prabu-Jeyabalan; Kelly Thayer; Celia A Schiffer
Journal:  Viruses       Date:  2010-11-12       Impact factor: 5.818

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.